… to that of magnetic resonance spectroscopy and MRI. … to neoadjuvant chemotherapy in a
human subject (16). DOS measurements were performed during neoadjuvant chemotherapy …

… optical spectroscopy is capable of distinguishing between tumor and surrounding breast …
We have applied this method to monitoring neoadjuvant chemotherapy response and have …

… optical index (TOI), predict pathologic complete response (pCR) in women undergoing breast
cancer neoadjuvant chemotherapy (… of California, Irvine (Irvine, CA), and delivered to six …

… and predicting breast cancer neoadjuvant chemotherapy pathological … optical spectroscopy
of neoadjuvant chemotherapy response in women with locally advanced breast cancer…

… optical spectroscopy in monitoring tumor response in patients … neoadjuvant treatment for
locally advanced breast cancer. We show that as early as 4 weeks, diffuse optical spectroscopy …

… the potential of diffuse optical spectroscopy for monitoring of patients with locally advanced
breast cancer (LABC) undergoing neoadjuvant chemotherapy. Fifteen women receiving …

… optical spectroscopy (DOS) has the potential to enable monitoring of tumor response during
chemotherapy… -negative breast cancer patients receiving neoadjuvant chemotherapy (NAC) …

… Diffuse optical spectroscopy (DOS) has been demonstrated capable of monitoring response
to neoadjuvant chemotherapy (NAC) in locally advanced breast cancer (LABC) patients. In …

… This study aimed to investigate the potential of diffuse optical spectroscopy (DOT) for
monitoring the responses of patients with breast cancer to neoadjuvant chemotherapy (NAC). …

… Breast cancer is considered one of the major cause of cancer… diagnosed breast cancers is
locally advanced breast cancer (… outcomes and required neoadjuvant chemotherapy (NAC) …